Invisible plastic fragments from common tableware are turning up in semen; now, researchers reveal how nanoscale particles may quietly sabotage male reproductive biology through cellular stress and self-destruction pathways.
Study:…
After a decade of work, researchers are closer than ever to a key breakthrough in kidney organ transplants: being able to transfer kidneys from donors with different blood types than the recipients, which could significantly speed up waiting…
Why are we able to recall only some of our past experiences? A new study led by Jun Nagai at the RIKEN Center for Brain Science in Japan has an answer. Surprisingly, it turns out that the brain cells responsible for stabilizing…
Lung cancer screening might be the best-kept secret in health care today. Only about 16 percent of those who are eligible in the U.S. get screened for lung cancer, but a study coming out in NEJM Catalyst on Wednesday provides a…
Drug Topics A study shows young adults with 3 or more COVID-19 vaccine doses experience fewer symptoms, emphasizing vaccination’s critical role in public health.
Link to study here
Young…
Washington, D.C. (October 14, 2025) — A new study led by researchers at the George Washington University and published through the DC Cohort, one of the largest HIV longitudinal studies in the United States, finds that nearly half of people…
A new study published in Nature’s Scientific Reports indicates that amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS) have an extremely high geographic association, even after controlling for race, gender, wealth,…
In recent years, the landscape of antiretroviral therapy (ART) for HIV has undergone significant transformations, largely driven by the introduction of more effective and safer drug options. Among these, two formulations of tenofovir, namely…
Lenacapavir, a long-acting injectable administered once every six months, could be a component of combination regimens for people starting HIV treatment for the first time, according to final results from the CALIBRATE study. After 132 weeks of…